The World Health Summit has proved itself the premier global health event of the year. Under the banner “Taking ...

The recent ceasefire agreement is bringing a fragile peace to Gaza. Aside from a cessation of hostilities, it has important ...

The integration of Bruton tyrosine kinase (BTK) inhibitors into first-line treatment regimens, in combination with ...

FACT: #COVID19 is NOT airborne”, declared a tweet from WHO in March, 2020. WHO did not officially accept until almost 2 years later that infection by SARS-CoV-2 could after all be caused by long-range ...

The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from ...

As the US foreign assistance architecture faces unprecedented dismantling, lessons from past crises take on urgent significance. Our new analysis of COVID-19 donor funding1 reveals a profound ...

Despite extraordinary scientific and medical resources, the US health-care system underperforms. In this Review we consider ...

International outcomes in breast, cervical, and ovarian cancers highlight opportunities to improve health-care delivery for ...

Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...

The REC-CAGEFREE I trial1 by Chao Gao and colleagues describes the results of a multicentre trial in which a paclitaxel drug-coated balloon (DCB) did not reach expected non-inferiority compared with a ...

Follicle-stimulating hormone (FSH), a glycoprotein secreted by gonadotroph cells of the anterior pituitary, is classically ...

Over the past two decades there have been tremendous advancements in the understanding of both the prevalence and the ...